General Information
edit

Website	syndax.com
Category	BioTech
Phone	781.419.1400
Email
Employees
Founded	2005
Description	Cancer Therapeutics Developer

Offices
edit

Headquarters

460 Totten Pond Road
Suite 650
Waltham, MA, 02451
USA

CEO

President

TOTAL	$9M
VENTURE FUNDING TOTAL	$9M
Series A, 3/10 Domain Associates MPM Capital Avalon Ventures Forward Ventures Pappas Ventures	$9M

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Syndax Pharmaceuticals added Joanna C. Horobin as President.

Posted 4/18/12 at 7:57pm
Syndax Pharmaceuticals added Arlene M. Morris as CEO.

Posted 4/18/12 at 7:57pm
Syndax Pharmaceuticals received $9M in Series A funding. (3/16/10)

Posted 3/15/10 at 11:10pm via onbiovc.com